BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 922723)

  • 21. Principal polypeptide target of carcinogen at the beginning of liver carcinogenesis by three carcinogens.
    Blackburn GR; Schnabel SJ; Danley JM; Hogue-Angeletti RA; Sorof S
    Cancer Res; 1982 Nov; 42(11):4664-72. PubMed ID: 7127303
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies.
    Groopman JD; Haugen A; Goodrich GR; Wogan GN; Harris CC
    Cancer Res; 1982 Aug; 42(8):3120-4. PubMed ID: 6807538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The particular traits of carcinogenesis induced in Wistar rats by aflatoxin B1. III. Porphyrins and the activity of gamma-glutamyltranspeptidase in primary hepatomas and in their tissue of origin.
    Zawirska B; Bednarz W
    Neoplasma; 1981; 28(1):35-49. PubMed ID: 6116200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A quantitative histochemical study of DNA and total protein in the livers of rats with transplantable ovarian tumor (strain OIa)].
    Ismailov BI; Arkhipova LD; Efimov ML
    Vopr Onkol; 1970; 16(1):113-4. PubMed ID: 5461572
    [No Abstract]   [Full Text] [Related]  

  • 25. Enhanced hepatotoxicity of aflatoxin B1 by pretreatment of rats with ethanol.
    Toskulkao C; Taycharpipranai S; Glinsukon T
    Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):477-91. PubMed ID: 6812183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sequential exposure to aflatoxin B1 and diethylnitrosamine on vascular and stomach tissue and additional target organs in rats.
    Newberne PM; Connor M
    Cancer Res; 1980 Nov; 40(11):4037-42. PubMed ID: 6781738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental study on selenic blockage of primary hepatocarcinoma induced by aflatoxin B1 in rats].
    Li WG; Shou LQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1987 Jan; 21(1):11-2. PubMed ID: 3109855
    [No Abstract]   [Full Text] [Related]  

  • 28. The reactivity and carcinogenicity of aflatoxin B1-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin B1.
    Swenson DH; Miller JA; Miller EC
    Cancer Res; 1975 Dec; 35(12):3811-23. PubMed ID: 1104159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study on the inhibition of aflatoxin B1 induced hepatocarcinogenesis by the Rhizopus delemar.
    Zhu CR; Du MJ; Lei DN; Wan LQ
    Mater Med Pol; 1989; 21(2):87-91. PubMed ID: 2518699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of dietary lipotrope and lipid content on aflatoxin B1, N-2-fluorenylacetamide, and 1,2-dimethylhydrazine carcinogenesis in rats.
    Rogers AE; Lenhart G; Morrison G
    Cancer Res; 1980 Aug; 40(8 Pt 1):2802-7. PubMed ID: 7388829
    [No Abstract]   [Full Text] [Related]  

  • 31. [The h-proteins of the livers of animals with different sensitivity to carcinogenic substances].
    Kaledin VI
    Vopr Onkol; 1972; 18(6):57-60. PubMed ID: 4625372
    [No Abstract]   [Full Text] [Related]  

  • 32. Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat.
    Wogan GN; Newberne PM
    Cancer Res; 1967 Dec; 27(12):2370-6. PubMed ID: 4295478
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of butylated hydroxyanisole pretreatment on in vitro hepatic aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation in rats.
    Jhee EC; Ho LL; Lotlikar PD
    Cancer Res; 1988 May; 48(10):2688-92. PubMed ID: 3129185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein turnover in microsomal subfractions of liver and Morris hepatomas 7800 and 9618A.
    Moyer GH; Pitot HC
    Cancer Res; 1973 Jun; 33(6):1316-25. PubMed ID: 4352368
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of the isolated perfused rat liver to study carcinogen-DNA adduct formation from aflatoxin B1 and sterigmatocystin.
    Essigmann JM; Donahue PR; Story DL; Wogan GN; Brunengraber H
    Cancer Res; 1980 Nov; 40(11):4085-91. PubMed ID: 6781740
    [No Abstract]   [Full Text] [Related]  

  • 36. Sequential morphologic changes in aflatoxin B carcinogenesis in the rat.
    Newberne PM; Wogan GN
    Cancer Res; 1968 Apr; 28(4):770-81. PubMed ID: 4296938
    [No Abstract]   [Full Text] [Related]  

  • 37. [Distribution of protein binding carcinogen in primary liver tumors induced by 3'methyl-4-dimethylaminoazobenzene in rats].
    Bannikov GA; Gel'shteĭn VI; Chipysheva TA
    Biull Eksp Biol Med; 1973 Mar; 75(1):90-2. PubMed ID: 4360359
    [No Abstract]   [Full Text] [Related]  

  • 38. Aflatoxicol and aflatoxins B1 and M1 in the tissues of pigs receiving aflatoxin.
    Trucksess MW; Stoloff L; Brumley WC; Wilson DM; Hale OM; Sangster LT; Miller DM
    J Assoc Off Anal Chem; 1982 Jul; 65(4):884-7. PubMed ID: 6811546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models.
    Groopman JD; Roebuck BD; Kensler TW
    Prog Clin Biol Res; 1992; 374():139-55. PubMed ID: 1320272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative studies of the nucleoli of Morris hepatomas, embryonic liver, and aflatoxin B1-treated liver of rats.
    Unuma T; Morris HP; Busch H
    Cancer Res; 1967 Nov; 27(11):2221-33. PubMed ID: 4294534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.